GENIX: Gene therapy & genome editing

Connect programme evidence to translation decisions.

Part of Advanced Therapies Intelligence

GENIX sits within the HERMS Advanced Therapies Intelligence domain. Complex translational evidence across gene therapy, cell therapy, exosomes and experimental design requires structured, traceable evaluation.

Discuss GENIX in a working session

Related HERMS solutions

HERMS provides decision support within a governed platform and does not replace qualified professional, regulatory or clinical judgement.

ENGINEERING INTELLIGENCE. REVOLUTIONIZING LIFE SCIENCES.

HERMS is the intelligence platform. Its applications are the decision engines. HERMS expert services support implementation and regulated execution of the HERMS intelligence ecosystem, from regulatory and market access to pharmacovigilance, compliance and quality.

Drug registration timelines by country · SFDA, MOHAP, EDE, EDA, EMA and FDA timelines · GCC central registration